Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,33 USD | -0,29% | +8,38% | +22,73% |
Omzet 2024 * | 167 mln. 157 mln. | Omzet 2025 * | 301 mln. 282 mln. | Marktkapitalisatie | 1,57 mld. 1,47 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -31 mln. -29,1 mln. | Nettowinst (verlies) 2025 * | 91 mln. 85,43 mln. | EV/omzet 2024 * | 9,79 x |
Nettoschuld 2024 * | 66,33 mln. 62,27 mln. | Nettoliquiditeiten 2025 * | 5,71 mln. 5,36 mln. | EV/omzet 2025 * | 5,2 x |
K/w-verhouding 2024 * |
-250
x | K/w-verhouding 2025 * |
7,08
x | Werknemers | 154 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,1% |
Recentste transcriptie over Avadel Pharmaceuticals plc
1 dag | -0,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 03-01-17 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 02-12-19 |
Scott Macke
COO | Chief Operating Officer | - | 01-09-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 01-12-18 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 03-01-17 |
Mark McCamish
BRD | Director/Board Member | 72 | 05-12-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 17,33 | -0,29% | 1 332 519 |
18-04-24 | 17,38 | -3,39% | 1 108 188 |
17-04-24 | 17,99 | -0,55% | 1 610 132 |
16-04-24 | 18,09 | +6,41% | 2 316 062 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,73% | 1,57 mld. | |
+24,60% | 654 mld. | |
+24,08% | 552 mld. | |
-5,63% | 356 mld. | |
+15,37% | 319 mld. | |
+7,38% | 295 mld. | |
+3,26% | 211 mld. | |
+0,78% | 206 mld. | |
-9,69% | 147 mld. | |
-6,63% | 144 mld. |